Italian Journal of Dermatology and Venereology最新文献

筛选
英文 中文
Staging, workup, neoadjuvant/adjuvant therapy, and treatment options for cutaneous squamous cell carcinoma. 皮肤鳞状细胞癌的分期、检查、新辅助/辅助治疗和治疗选择。
IF 2.1 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2026-11-09 DOI: 10.23736/S2784-8671.26.08667-6
Connor K Sisk, Victoria Jiminez, Michael Anderson, Hamza Malick, Umer Nadir, George M Jeha, Stanislav N Tolkachjov
{"title":"Staging, workup, neoadjuvant/adjuvant therapy, and treatment options for cutaneous squamous cell carcinoma.","authors":"Connor K Sisk, Victoria Jiminez, Michael Anderson, Hamza Malick, Umer Nadir, George M Jeha, Stanislav N Tolkachjov","doi":"10.23736/S2784-8671.26.08667-6","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08667-6","url":null,"abstract":"<p><p>Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer worldwide and represents a growing source of morbidity and mortality. Incidence continues to rise globally, driven by an aging population, cumulative ultraviolet exposure, and increasing prevalence of high-risk patient populations. While most cSCCs follow an indolent course, a clinically meaningful subset can demonstrate aggressive behavior, highlighting the need for accurate risk stratification and individualized management strategies. This narrative review synthesizes contemporary evidence regarding the clinical presentation, tumor biology, diagnostic evaluation, staging systems, and treatment paradigms for cSCC with emphasis on emerging prognostic tools shaping future care. We summarize key clinical and histopathologic features associated with adverse outcomes, including depth of invasion, differentiation, and perineural involvement, and review current imaging and nodal assessment strategies. Staging frameworks, including American Joint Committee on Cancer (AJCC), Brigham and Women's Hospital (BWH), and evolving stages of the National Comprehensive Cancer Network (NCCN) systems, are discussed alongside newer models such as risk-integrated squamous cell carcinoma staging, which aim to improve outcome discrimination. Treatment approaches encompassing surgery, radiation therapy, and systemic immunotherapy are reviewed, with particular attention to risk-adapted use of Mohs micrographic surgery, adjuvant radiation therapy (ART), and neoadjuvant or definitive programmed cell death protein-1 (PD-1) blockade for advanced disease. Finally, we examine emerging molecular prognostic assays, including gene expression profiling (GEP), that offer biologic insight beyond traditional clinicopathologic factors and may refine decisions regarding surveillance and treatment escalation. As the burden of cSCC continues to expand, integrated frameworks incorporating clinical, histopathologic, and molecular data will be essential for optimizing outcomes while minimizing patient and system-level burdens, particularly for identifying tumors requiring treatment escalation.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149378880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psoriasis occurrence in patients with atopic dermatitis treated with dupilumab and tralokinumab. 特应性皮炎患者用杜匹单抗和曲罗单抗治疗的牛皮癣发生率。
IF 2.1 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2026-11-09 DOI: 10.23736/S2784-8671.26.08612-3
Luisa Boeti, Gennaro M Falco, Nicoletta Bernardini, Ersilia Tolino, Niccolò Gori, Clara DE Simone, Ketty Peris, Giacomo Caldarola
{"title":"Psoriasis occurrence in patients with atopic dermatitis treated with dupilumab and tralokinumab.","authors":"Luisa Boeti, Gennaro M Falco, Nicoletta Bernardini, Ersilia Tolino, Niccolò Gori, Clara DE Simone, Ketty Peris, Giacomo Caldarola","doi":"10.23736/S2784-8671.26.08612-3","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08612-3","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149378879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of paradoxical pustular psoriasis and alopecia of the scalp caused by infliximab in a patient affected by Crohn disease. 克罗恩病患者英夫利昔单抗引起的矛盾脓疱性牛皮癣和头皮脱发的病例。
IF 2.1 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2026-10-29 DOI: 10.23736/S2784-8671.26.08265-4
Chiara Bocchi, Lucrezia Pacetti, Simone Cavaliere, Alessandro Borghi, Natale Schettini
{"title":"A case of paradoxical pustular psoriasis and alopecia of the scalp caused by infliximab in a patient affected by Crohn disease.","authors":"Chiara Bocchi, Lucrezia Pacetti, Simone Cavaliere, Alessandro Borghi, Natale Schettini","doi":"10.23736/S2784-8671.26.08265-4","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08265-4","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A staged, function-preserving approach for a massive lentigo maligna crossing the lip mucocutaneous junction. 一种分阶段、保留功能的方法治疗跨越唇部粘膜皮肤交界处的巨大恶性黄斑。
IF 2.1 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2026-10-29 DOI: 10.23736/S2784-8671.26.08633-0
Davide Bertolla, Federico Tartari, Alfonso Motolese, Anna R Lombardi, Alessandro Borghi, Andrea Conti
{"title":"A staged, function-preserving approach for a massive lentigo maligna crossing the lip mucocutaneous junction.","authors":"Davide Bertolla, Federico Tartari, Alfonso Motolese, Anna R Lombardi, Alessandro Borghi, Andrea Conti","doi":"10.23736/S2784-8671.26.08633-0","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08633-0","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapid clinical improvement of erythrodermic-onset psoriasis with bimekizumab. 比美珠单抗对红皮病型银屑病的快速临床改善。
IF 2.1 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2026-10-29 DOI: 10.23736/S2784-8671.26.08681-0
Andrea Coretti, Claudia Lasagni, Caterina Longo
{"title":"Rapid clinical improvement of erythrodermic-onset psoriasis with bimekizumab.","authors":"Andrea Coretti, Claudia Lasagni, Caterina Longo","doi":"10.23736/S2784-8671.26.08681-0","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08681-0","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The new revolution in the treatment of chronic urticaria, present and future of an effective and safe approach. 慢性荨麻疹治疗的新革命,现在和未来的有效和安全的方法。
IF 2.1 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2026-10-29 DOI: 10.23736/S2784-8671.26.08590-7
Ana M Giménez-Arnau, Francesca Barei, Andaç Salman
{"title":"The new revolution in the treatment of chronic urticaria, present and future of an effective and safe approach.","authors":"Ana M Giménez-Arnau, Francesca Barei, Andaç Salman","doi":"10.23736/S2784-8671.26.08590-7","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08590-7","url":null,"abstract":"<p><p>Chronic spontaneous urticaria (CSU) is a heterogeneous mast cell-driven disease associated with a substantial burden on patients' quality of life. Although most patients achieve disease control with guideline-recommended therapies, a relevant proportion remains refractory, highlighting important unmet needs. This narrative review summarizes current, emerging, and investigational treatments for CSU, discussing them with a pathogenesis-driven and endotype-oriented approach. Established therapies, including second-generation H1-antihistamines and omalizumab, are discussed alongside recently approved and upcoming agents such as dupilumab and Bruton's tyrosine kinase inhibitors, particularly remibrutinib. In addition, novel strategies targeting mast cell survival and activation (antireceptor tyrosine kinase therapies), intracellular signaling pathways (Janus Kinase and Tyrosine kinase 2inhibitors), immunoglobulin E-independent activation (Mas-related G protein-coupled receptor X2 antagonists), and next-generation anti-immunoglobulin E antibodies are reviewed. Beyond symptom control, the concepts of complete disease control, remission, relapse, and disease modification are examined. The evolving therapeutic landscape of CSU is expected to enable a more personalized management, with the potential to achieve sustained remission and, ultimately, disease modification in selected patients.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What's new in wound care: dermatological pearls from the 99th National Congress of the Italian Society of Medical, Surgical, Aesthetic Dermatology and Sexually Transmitted Diseases (SIDeMaST). 伤口护理的新进展:来自第99届意大利医学、外科、美容皮肤病学和性传播疾病学会(SIDeMaST)全国大会的皮肤病珍珠。
IF 2.1 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2026-10-29 DOI: 10.23736/S2784-8671.26.08749-9
Emanuele Scala, Valentina Dini, Chiara Fiorentini, Federico Garbarino, Agata Janowska, Andrea Marani, Davide Melandri, Andrea Michelerio, Paola Monari, Nicolò Mori, Alberico Motolese, Marco Romanelli, Linda Tognetti, Alessia Paganelli
{"title":"What's new in wound care: dermatological pearls from the 99th National Congress of the Italian Society of Medical, Surgical, Aesthetic Dermatology and Sexually Transmitted Diseases (SIDeMaST).","authors":"Emanuele Scala, Valentina Dini, Chiara Fiorentini, Federico Garbarino, Agata Janowska, Andrea Marani, Davide Melandri, Andrea Michelerio, Paola Monari, Nicolò Mori, Alberico Motolese, Marco Romanelli, Linda Tognetti, Alessia Paganelli","doi":"10.23736/S2784-8671.26.08749-9","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08749-9","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An overlap between pyoderma vegetans and hidradenitis suppurativa. 素食性脓皮病和化脓性汗腺炎的重叠。
IF 2.1 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2026-10-29 DOI: 10.23736/S2784-8671.26.08629-9
Francesca Ambrogio, Alexandre R Meduri, Domenico Bonamonte, Gerardo Cazzato, Caterina Foti, Benedetta Tirone
{"title":"An overlap between pyoderma vegetans and hidradenitis suppurativa.","authors":"Francesca Ambrogio, Alexandre R Meduri, Domenico Bonamonte, Gerardo Cazzato, Caterina Foti, Benedetta Tirone","doi":"10.23736/S2784-8671.26.08629-9","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08629-9","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-exposure prophylaxis for HIV: a review for dermatovenereologists. HIV暴露前预防:皮肤性病学家综述。
IF 2.1 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2026-10-13 DOI: 10.23736/S2784-8671.26.08434-3
Luigi Pisano, Martina Turco, Nicola Pimpinelli
{"title":"Pre-exposure prophylaxis for HIV: a review for dermatovenereologists.","authors":"Luigi Pisano, Martina Turco, Nicola Pimpinelli","doi":"10.23736/S2784-8671.26.08434-3","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08434-3","url":null,"abstract":"<p><p>Human immunodeficiency virus (HIV) infection remains a significant public health issue, with 112,883 new diagnoses reported in Europe in 2023. The rise is particularly notable in Eastern Europe, where new cases increased by 20% between 2010 and 2023. Late diagnosis is a major barrier to HIV control, with nearly 50% of new infections in Europe - and up to 60% in Italy - detected at an advanced stage. Dermatovenereologists are key in early detection, as over 90% of people living with HIV show at least one HIV-related dermatologic condition before diagnosis. Thus, dermatovenereology services are well-positioned to promote routine HIV testing and prevention. Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention method but is unevenly implemented across Europe. In Italy, PrEP is mostly prescribed by infectious disease specialists, except at a pioneering sexually transmitted infections (STI) center in Florence where dermatovenereologists can also prescribe it. Expanding this prescribing authority nationwide could improve access and prevention efforts among underserved populations. Integrating PrEP into dermatovenereology would enhance the continuum of care by linking STI screening, treatment, counseling, and HIV prevention, supporting UNAIDS' goal of ending AIDS by 2030. This narrative review summarizes key studies leading to PrEP approval, outlines approved administration methods for at-risk groups, discusses potential side effects, and highlights emerging therapeutic options under regulatory review (such as long-acting PrEP). It aims to equip dermatovenereologists with all the necessary tools to prescribe and manage PrEP effectively during follow-up.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149181888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MicroRNA expression in vulvar lichen sclerosus keratinocytes and fibroblasts: further evidence and possible pathogenetic implications from an observational study. 外阴硬化地衣角质形成细胞和成纤维细胞中的MicroRNA表达:一项观察性研究的进一步证据和可能的发病意义。
IF 2.1 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2026-10-08 DOI: 10.23736/S2784-8671.26.08591-9
Alessandro Borghi, Fernanda Martini, Lucilla D'Abundo, Cristian Bassi, Lucia Oton Gonzalez, Lucrezia Pacetti, Massimo Negrini, Monica Corazza
{"title":"MicroRNA expression in vulvar lichen sclerosus keratinocytes and fibroblasts: further evidence and possible pathogenetic implications from an observational study.","authors":"Alessandro Borghi, Fernanda Martini, Lucilla D'Abundo, Cristian Bassi, Lucia Oton Gonzalez, Lucrezia Pacetti, Massimo Negrini, Monica Corazza","doi":"10.23736/S2784-8671.26.08591-9","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08591-9","url":null,"abstract":"<p><strong>Background: </strong>It seems established that genetic and epigenetic determinants drive the multifactorial pathogenic processes in vulvar lichen sclerosus (VLS). Aberrant expression of microRNAs (miRNAs) has been observed in a few studies suggesting their potential involvement. Our aim was to assess the expression of miRNAs both in VLS and in healthy keratinocytes and fibroblasts cultured separately.</p><p><strong>Methods: </strong>In this observational study, five VLS and five healthy skin tissue specimens were used to derive independent keratinocyte and fibroblast cultures. Total RNA, including miRNA, was isolated from cells, quantified and used to prepare a miRNA library. The quality and quantity of miRNA libraries were analyzed and sequenced. Differentially expressed miRNAs have been identified using DESeq2 bioconductor package.</p><p><strong>Results: </strong>The differential analysis led to the identification of 171 and 111 microRNAs with an expression difference of at least 1.5-fold between VLS and healthy samples, in keratinocytes and fibroblasts, respectively. More than 80% of the 111 microRNAs identified as differentially expressed in fibroblasts were also found to be differentially expressed in keratinocytes. Several dysregulated miRNAs are involved in inflammation and fibrotic processes, namely miR-10a-5p and 3p, miR-143-3p and 5p, miR-181a-5p and 3p, miR-181b-5p and 3p, miR-21-3p, miR-146b-5p and miR-29c.</p><p><strong>Conclusions: </strong>Our results showed a clear separation of VLS keratinocytes and fibroblasts from healthy cells in terms of miRNA expression. It is noteworthy that the most dysregulated miRNAs are implicated in inflammatory and fibrotic pathways. It is conceivable that miRNA expression is functional in regulating pathogenetic mechanisms of LS.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149127430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书